Tilray Brands, Inc. (TSX:TLRY)

Canada · Delayed Price · Currency is CAD

13.18

-0.39 (-2.87%)

At close: Jan 16, 2026

-22.01% (1Y)

Market Cap	1.53B
Revenue (ttm)	1.17B
Net Income (ttm)	-2.94B
Shares Out	n/a
EPS (ttm)	-29.13
PE Ratio	n/a
Forward PE	22.71
Dividend	n/a
Ex-Dividend Date	n/a

Volume	376,502
Average Volume	786,302
Open	13.44
Previous Close	13.57
Day's Range	13.03 - 13.44
52-Week Range	4.85 - 32.30
Beta	2.12
RSI	47.66
Earnings Date	Jan 8, 2026

About Tilray Brands

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the c... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

CEO Irwin Simon

Employees 2,842

Stock Exchange Toronto Stock Exchange

Ticker Symbol TLRY

Full Company Profile

Financial Performance

In 2025, Tilray Brands's revenue was $821.31 million, an increase of 4.10% compared to the previous year's $788.94 million. Losses were -$2.19 billion, 792.6% more than in 2024.

Financial numbers in USD Financial Statements

News

3 Canadian Marijuana Stocks For Investors In 2026

The cannabis industry is set to reach new horizons in 2026. More companies are coming together to take the industry to a level yet to be seen. With bigger and better partnerships taking effect this ye...

1 day ago - MarijuanaStocks

What's Next for Tilray Brands After Posting Record Q2 Revenues?

TLRY posts record Q2 revenues of $217.5M as international cannabis and distribution strength outweighs beverage headwinds.

3 days ago - Nasdaq

Should You Buy, Sell or Hold TLRY Stock Post Q2 Earnings?

Tilray Brands posts record Q2 revenue of $217.5M, beats sales estimates, reaffirms EBITDA outlook as international cannabis and distribution offset beverage weakness.

4 days ago - Nasdaq

International Cannabis Expansion Gives Tilray Positive 2026 Outlook

7 days ago - Seeking Alpha

Tilray Valuation Attractive With Strong Growth Overseas, Analyst Says

Tilray Brands Inc. (NASDAQ: TLRY) on Thursday reported quarterly earnings of one cent per share, which beat the Street estimate for a loss of 20 cents . Quarterly revenue came in at $217.51 million, ...

8 days ago - Benzinga

Tilray Stock Couldn’t Sustain Its Trump Gains. How Cannabis Earnings Could Help.

8 days ago - Barron's

These Stocks Are Moving the Most Today: Oklo, Vistra, Opendoor, Intel, GM, Revolution Medicines, Tilray, and More

8 days ago - Barron's

Marijuana industry taking fight against Wall Street blockades straight to Trump

Bankers have argued that Pot Inc.'s far-bigger prospective business – recreational use that would include the smoking of joints and ingesting high-inducing gummies – wasn't specifically addressed by t...

8 days ago - New York Post

Tilray Brands (TLRY) Surges on Record Revenue Beat

8 days ago - GuruFocus

Stock Market Today: Nasdaq 100, S&P 500 Futures Gain As Investors Await December Jobs Report— General Motors, Offerpad, Tilray In Focus

U.S. stock futures pared earlier losses to advance on Friday after a mixed Thursday. Futures of major benchmark indices were trading higher. Rising unrest in Iran gripped investor sentiment as WTI Cru...

8 days ago - Benzinga